All In Biotech

Free tool

FAERS Monitor: Fml Forte

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019216 or its brand name (Fml Forte, Fluorometholone). Reports on generic versions are filed under their own applications.

Reports

2,748

Serious

1,456

53% of reports

Hospitalization

731

Death reported

308

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure318
  • fatigue201
  • eye pain197
  • drug ineffective192
  • off label use187
  • diarrhoea170
  • headache168
  • dyspnoea162
  • arthralgia161
  • condition aggravated146
  • dizziness145
  • pruritus139
  • nausea138
  • maternal exposure during pregnancy136
  • asthenia135

Reports by year received

View as table
YearReports
200410
20055
20069
20079
20087
200915
201029
201128
201262
201346
201451
201568
2016121
2017125
2018135
2019147
2020384
2021173
2022215
2023229
2024284
2025330
2026266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,411 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
treatment failureSignal31829.526.68,725
eye painSignal19726.823.44,866
maternal exposure during pregnancySignal13611.79.91,323
condition aggravatedSignal1463.73.1286
arthralgiaSignal1613.02.6212
pruritusSignal1392.82.4158
astheniaSignal1352.72.3151
dizzinessSignal1452.21.999
dyspnoeaSignal1622.21.9106
headacheSignal1682.11.892
diarrhoeaSignal1702.01.789
fatigue2012.01.7100
off label use1871.61.447
nausea1381.31.112
drug ineffective1921.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.